Single-cell RNA sequencing reveals the mechanism of sonodynamic therapy combined with a RAS inhibitor in the setting of hepatocellular carcinoma

BACKGROUND: Ras activation is a frequent event in hepatocellular carcinoma (HCC). Combining a RAS inhibitor with traditional clinical therapeutics might be hampered by a variety of side effects, thus hindering further clinical translation. Herein, we report on integrating an IR820 nanocapsule-augmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Bolin, Yuan, Yanchi, Liu, Jiayin, Shang, Haitao, Dong, Jing, Liang, Xitian, Wang, Dongxu, Chen, Yichi, Wang, Chunyue, Zhou, Yang, Jing, Hui, Cheng, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199394/
https://www.ncbi.nlm.nih.gov/pubmed/34118951
http://dx.doi.org/10.1186/s12951-021-00923-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199394/
https://www.ncbi.nlm.nih.gov/pubmed/34118951
http://dx.doi.org/10.1186/s12951-021-00923-3

Ejemplares similares